1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: October 26 - November 1, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: October 26 - November 1, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 10/28/2025
Location: Washington, DC
Subject: CEO Roundtable on Cancer Annual Meeting; Speaker: Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, and other stakeholders

Event Date: 10/28/2025
Location: Silver Spring, MD
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: American Heart Association representatives

Event Date: 10/29/2025
Location: North Bethesda, MD
Subject: GRx+Biosims 2025 Conference; Speaker: Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 10/29/2025
Location: North Bethesda, MD
Subject: Association of Accessible Medicines (AAM) Board Member Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Association of Accessible Medicines (AAM) representatives

Event Date: 10/30/2025
Location: New York, NY
Subject: Galien Forum; Speaker: Life Science Innovation
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

Event Date: 10/26/2025
Location: Washington, DC
Subject: 2025 Future of Health Data Summit; Speaker: Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Official Name: Sean R. Keveney, Chief Counsel

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

No Significant Event

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 10/30/2025
Location: Virtual
Subject: AI Issues of Mutual Interest
FDA Participant/Group: JARED SEEHAFER; 
Non FDA Participant/Group: Krishna Kavi, Maulik Shah, Shubhra Jain (Hippocratic AI);

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: George F. Tidmarsh, M.D., Ph.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

Event Date: 10/28/2025
Location: Washington, DC
Subject: Food and Drug Law Institute (FDLI) 2025 Tobacco and Nicotine Products Regulation and Policy Conference; Speaker: Keynote Address
FDA Participant/Group: CRISTI STARK; JOHN VERBETEN; 
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine

No Significant Event

Back to Top